HAE
Haemonetics Corporation
108.50$
-0.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.7% | +2.1% | -2.1% | +2.8% | +0.9% | -5.1% | -2.8% | +1.8% | +3.6% | +2.2% | -2.0% | – | |
| – | +2.5% | +2.0% | +1.6% | -1.6% | -3.7% | +0.0% | -12.9% | +11.1% | +2.5% | +0.4% | -7.8% | – | |
| – | +8.4% | +2.2% | -5.1% | +6.6% | +4.6% | -9.0% | +5.5% | -4.4% | +4.4% | +3.6% | +2.3% | – | |
| – | +4.7% | +84.4% | -40.9% | -2.1% | +12.0% | +0.8% | +1.9% | -10.7% | -1.6% | +1.1% | +12.1% | – | |
| – | +6.5% | -3.3% | +0.2% | -1.2% | -0.5% | +8.2% | -3.8% | -8.2% | +5.2% | +13.1% | -1.6% | – | |
| – | +2.7% | +14.4% | -12.2% | 0.0% | +1.0% | -7.4% | +5.8% | -15.8% | +4.9% | +20.5% | -1.0% | – | |
| – | +30.2% | -34.9% | +32.8% | +30.0% | +14.2% | -12.8% | +4.7% | +24.9% | +3.4% | -26.0% | +11.7% | – | |
| – | -21.1% | +235.0% | +6.6% | +0.5% | +30.3% | -93.4% | +581.1% | +77.1% | +12.6% | -33.8% | +83.9% | – | |
| – | +34.1% | -46.8% | +99.5% | -4.3% | +11.7% | +41.7% | -36.1% | +13.5% | +16.9% | -147.4% | – | – | |
| – | +61.4% | -76.2% | +173.7% | +30.4% | +14.3% | +2.7% | -12.7% | +13.1% | +20.9% | -154.2% | – | – | |
| – | +25.4% | -34.8% | +88.4% | -11.8% | +10.8% | +54.6% | -41.3% | +13.7% | +15.7% | -145.0% | – | – | |
| – | +25.5% | -17.1% | +17.1% | +11.1% | +6.9% | +4.0% | -5.3% | -7.4% | +10.1% | -95.5% | +1,639.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.